Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-7-5
pubmed:abstractText
The elevated level of group IIA secretory phospholipase A(2) (sPLA(2)-IIA) activity contributes to neurodegeneration in the cerebral cortex after ischemia. The up-regulation of cyclooxygenase-2 (COX-2) is also relevant to cerebral ischemia in humans. Studies of ischemia with COX-2 inhibitors suggest a clinical benefit. In the present study, we investigated effects of S-2474 on sPLA(2)-IIA-induced cell death in primary cultures of rat cortical neurons, which was established as an in vitro model of brain ischemia. S-2474 is a novel nonsteroidal anti-inflammatory drug (NSAID), which inhibits COX-2 and contains the di-tert-butylphenol antioxidant moiety. S-2474 significantly prevented neurons from undergoing sPLA(2)-IIA-induced cell death. S-2474 completely ameliorated sPLA(2)-IIA-induced apoptotic features such as the condensation of chromatin and the fragmentation of DNA. sPLA(2) also generated neurotoxic prostaglandin D(2) (PGD(2)) and free radicals from neurons before cell death. S-2474 significantly inhibited the sPLA(2)-IIA-induced generation of PGD(2). The present cortical cultures contained few non-neuronal cells, indicating that S-2474 affected neuronal survival directly, but not indirectly via non-neuronal cells. The inhibitory effect of S-2474 on COX-2 might contribute to its neuroprotective effect. In conclusion, S-2474 exhibits neuroprotective effects against sPLA(2)-IIA. Furthermore, the present study suggests that S-2474 may possess therapeutic potential for stroke via ameliorating neurodegeneration.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Carbamates, http://linkedlifedata.com/resource/pubmed/chemical/Chromatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic S-Oxides, http://linkedlifedata.com/resource/pubmed/chemical/Group II Phospholipases A2, http://linkedlifedata.com/resource/pubmed/chemical/Indolizines, http://linkedlifedata.com/resource/pubmed/chemical/Phospholipases A, http://linkedlifedata.com/resource/pubmed/chemical/S 2474, http://linkedlifedata.com/resource/pubmed/chemical/Tetrazolium Salts, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/indoxam, http://linkedlifedata.com/resource/pubmed/chemical/thiazolyl blue
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0028-3908
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
174-84
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15996566-Animals, pubmed-meshheading:15996566-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:15996566-Apoptosis, pubmed-meshheading:15996566-Carbamates, pubmed-meshheading:15996566-Cell Count, pubmed-meshheading:15996566-Cell Size, pubmed-meshheading:15996566-Cells, Cultured, pubmed-meshheading:15996566-Cerebral Cortex, pubmed-meshheading:15996566-Chromatin, pubmed-meshheading:15996566-Cyclic S-Oxides, pubmed-meshheading:15996566-Dose-Response Relationship, Drug, pubmed-meshheading:15996566-Drug Interactions, pubmed-meshheading:15996566-Embryo, Mammalian, pubmed-meshheading:15996566-Group II Phospholipases A2, pubmed-meshheading:15996566-Humans, pubmed-meshheading:15996566-In Situ Nick-End Labeling, pubmed-meshheading:15996566-Indolizines, pubmed-meshheading:15996566-Neurons, pubmed-meshheading:15996566-Phospholipases A, pubmed-meshheading:15996566-Rats, pubmed-meshheading:15996566-Rats, Sprague-Dawley, pubmed-meshheading:15996566-Tetrazolium Salts, pubmed-meshheading:15996566-Thiazoles
pubmed:year
2005
pubmed:articleTitle
S-2474, a novel nonsteroidal anti-inflammatory drug, rescues cortical neurons from human group IIA secretory phospholipase A(2)-induced apoptosis.
pubmed:affiliation
Discovery Research Laboratories, Shionogi and Co., Ltd., 12-4, Sagisu 5-Choume, Fukushima-ku, Osaka 553-0002, Japan. yagami@pharmac.med.yokohama-cu.ac.jp
pubmed:publicationType
Journal Article, Comparative Study